Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Can EGFR mutation status be reliably determined in pre-operative needle biopsies from adenocarcinomas of the lung?

Lindahl KH, Sørensen FB, Jonstrup SP, Olsen KE, Loeschke S.

APMIS. 2015 Apr;123(4):289-97. doi: 10.1111/apm.12350. Epub 2014 Dec 31.

PMID:
25556929
2.

Decrease in thyroid adenoma associated (THADA) expression is a marker of dedifferentiation of thyroid tissue.

Kloth L, Belge G, Burchardt K, Loeschke S, Wosniok W, Fu X, Nimzyk R, Mohamed SA, Drieschner N, Rippe V, Bullerdiek J.

BMC Clin Pathol. 2011 Nov 4;11:13. doi: 10.1186/1472-6890-11-13.

3.

Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.

Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J.

Genes Chromosomes Cancer. 2008 Jan;47(1):56-63.

PMID:
17943974
4.

HMGA2 expression in a canine model of prostate cancer.

Winkler S, Murua Escobar H, Meyer B, Simon D, Eberle N, Baumgartner W, Loeschke S, Nolte I, Bullerdiek J.

Cancer Genet Cytogenet. 2007 Sep;177(2):98-102.

PMID:
17854662
5.

Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets.

Watz H, Engels K, Loeschke S, Amthor M, Kirsten D, Magnussen H.

Thorax. 2007 Jun;62(6):559. No abstract available.

6.

HMGA2 overexpression in non-small cell lung cancer.

Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, Vollmer E, Bullerdiek J.

Mol Carcinog. 2007 Jul;46(7):503-11.

PMID:
17477356
7.

Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.

Drieschner N, Belge G, Rippe V, Meiboom M, Loeschke S, Bullerdiek J.

Thyroid. 2006 Nov;16(11):1091-6.

PMID:
17123335
8.

Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer.

Winkler S, Reimann-Berg N, Murua Escobar H, Loeschke S, Eberle N, Höinghaus R, Nolte I, Bullerdiek J.

Cancer Genet Cytogenet. 2006 Sep;169(2):154-8.

PMID:
16938574
9.

The HOPE technique opens up a multitude of new possibilities in pathology.

Vollmer E, Galle J, Lang DS, Loeschke S, Schultz H, Goldmann T.

Rom J Morphol Embryol. 2006;47(1):15-9. Review.

10.

Enhanced molecular analyses by combination of the HOPE-technique and laser microdissection.

Goldmann T, Burgemeister R, Sauer U, Loeschke S, Lang DS, Branscheid D, Zabel P, Vollmer E.

Diagn Pathol. 2006 Mar 31;1:2.

11.

HMGA1 proteins in human atherosclerotic plaques.

Schlueter C, Hauke S, Loeschke S, Wenk HH, Bullerdiek J.

Pathol Res Pract. 2005;201(2):101-7.

PMID:
15901130
12.

Improved detection of mycobacterial DNA by PCR in formalin-fixed, paraffin-embedded tissues using thin sections.

Loeschke S, Goldmann T, Vollmer E.

Pathol Res Pract. 2005;201(1):37-40.

PMID:
15807309
13.

The HOPE-technique permits Northern blot and microarray analyses in paraffin-embedded tissues.

Goldmann T, Flohr AM, Murua Escobar H, Gerstmayer B, Janssen U, Bosio A, Loeschke S, Vollmer E, Bullerdiek J.

Pathol Res Pract. 2004;200(7-8):511-5.

PMID:
15462498
14.

High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade.

Flohr AM, Rogalla P, Bonk U, Puettmann B, Buerger H, Gohla G, Packeisen J, Wosniok W, Loeschke S, Bullerdiek J.

Histol Histopathol. 2003 Oct;18(4):999-1004.

PMID:
12973668
15.

Cost-effective gel documentation using a web-cam.

Goldmann T, Zyzik A, Loeschke S, Lindsay W, Vollmer E.

J Biochem Biophys Methods. 2001 Dec 4;50(1):91-5.

PMID:
11714515
16.

[Melanotic neuroectodermal tumor of infancy].

Rustemeyer J, Thieme V, Loeschke S, Bremerich A, Kössling FK.

Klin Padiatr. 2001 Mar-Apr;213(2):69-73. German.

PMID:
11305195
17.

[Post-traumatic edema as a limiting factor in early functional treatment measures and its pharmacodynamic modification].

Nissen R, Loeschke S, Peters A.

Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1989:475-8. German.

PMID:
2485152
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk